Skip to main content
. 2022 May 17;12:8230. doi: 10.1038/s41598-022-12301-6

Figure 11.

Figure 11

The prognostic value of IGSPP for ICI treatment. (AD) Scores of TIDE, MSI, T cell exclusion and T cell dysfunction in different IGSPP groups. The Wilcoxon test was used to evaluate the difference (*P < 0.05, **P < 0.01, ***P < 0.001). (EG) The 1-, 3- and 5-year ROC curves based on the IGSPP, TIS and TIDE scores of the TCGA cohort.